NTBLQ (Notable Labs) Additional Paid-In Capital : $97.51 Mil(As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Additional Paid-In Capital?

Notable Labs's quarterly additional paid-in capital increased from Dec. 2023 ($96.52 Mil) to Mar. 2024 ($96.66 Mil) and increased from Mar. 2024 ($96.66 Mil) to Jun. 2024 ($97.51 Mil).

Notable Labs's annual additional paid-in capital increased from Dec. 2021 ($2.69 Mil) to Dec. 2022 ($34.06 Mil) and increased from Dec. 2022 ($34.06 Mil) to Dec. 2023 ($96.52 Mil).

Notable Labs Additional Paid-In Capital Historical Data

The historical data trend for Notable Labs's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Additional Paid-In Capital Chart

Notable Labs Annual Data

Trend

Dec21

Dec22

Dec23

Additional Paid-In Capital

2.69

34.06

96.52

Notable Labs Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Dec23	Mar24	Jun24
Additional Paid-In Capital	Get a 7-Day Free Trial			-	-	96.52	96.66	97.51

Notable Labs Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Notable Labs Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Notable Labs's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Notable Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (OTCPK:NTBLQ) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

320 Hatch Drive, Foster City, CA, USA, 94404

Website

https://notablelabs.com

Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.